Position in RPRX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$6,852,987
New position
Shares Held
122,222
first reported quarter
Ownership
0.021%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#188
of 641 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ASR Vermogensbeheer N.V. holds $37,601,819 across 6 Biotechnology names. RPRX ranks #3 (18.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
25,471 | $12,652,209 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
15,098 | $9,414,206 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
122,222 | $6,852,987 | |
| 4 | INCY |
Incyte Corp
|
57,499 | $6,518,086 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
5,375 | $1,618,036 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,917 | $546,295 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,852,987 | 122,222 | Shares | Defined | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||